Piper Sandler analyst John Barnidge raised the firm’s price target on Horace Mann (HMN) to $42 from $36 and keeps a Neutral rating on the shares. The firm notes there was improvement in P&C underwriting along with continued persistently better than expected earnings emergence out of Supplemental & Group Benefits. Life & Retirement is continuing to be impacted by some elevated mortality that is not anticipated to persist, Piper adds.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HMN: